3 results match your criteria: "The Montreal Childrens' Hospital[Affiliation]"
J Surg Res
March 2024
Harvey E. Beardmore Division of Pediatric Surgery, The Montreal Childrens' Hospital, McGill University, Montreal, Quebec, Canada. Electronic address:
Introduction: Recent studies revealed that coronavirus disease 2019 (COVID-19) negatively impacted residency programs worldwide, particularly procedure-based programs. However, most studies are from high-income countries, with scarce data from low- and middle-income countries. Pandemic effects on surgical training were likely worse in strictly apprenticeship models relying heavily on surgical volume as opposed to competency-based programs.
View Article and Find Full Text PDFCochrane Database Syst Rev
August 2001
The Montreal Childrens' Hospital, Room C538E, 2300 Tupper Street, Montreal, Quebec, CANADA, H3H 1P3.
Background: Several randomized controlled trials have examined, with conflicting results, the efficacy of the addition of anticholinergics to beta2 agonists in acute pediatric asthma. The pooling for a larger number of randomized controlled trials may provide not only greater power for detecting group differences and also provide better insight into the influence of patients' characteristics and treatment modalities on efficacy.
Objectives: The aims of this study were to estimate the therapeutic and adverse effects attributable to the addition of inhaled anticholinergics to beta2 agonists in acute pediatric asthma.
Cochrane Database Syst Rev
July 2000
The Montreal Childrens' Hospital, Room C538E, 2300 Tupper Street, Montreal, Quebec, Canada, H3H 1P3.
Background: Anti-cholinergic agents and beta2-agonist drugs are both bronchodilators used to reverse acute bronchospasm in children with asthma. These drugs have different modes of action, so may have complementary or additive effects.
Objectives: The objective of this review was to assess the effects of adding inhaled anti-cholinergics to beta2-agonists in acute paediatric asthma.